Aleksander A. Krag
Elite in Alcoholic Cirrhosis

Aleksander A. Krag

Gastroenterology
Sdr. Boulevard 29, 
Odense C, DK 
Elite in Alcoholic Cirrhosis
Sdr. Boulevard 29, 
Odense C, DK 
OverviewLocationsClinical Research

Overview

Aleksander Krag is a Gastroenterologist in Odense C, Denmark. Mr. Krag is rated as an Elite expert by MediFind in the treatment of Alcoholic Cirrhosis. His top areas of expertise are Cirrhosis, Portal Hypertension, Ascites, Liver Transplant, and Endoscopy.

His clinical research consists of co-authoring 298 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 14 articles in the study of Alcoholic Cirrhosis.

Specialties
Gastroenterology
Gender
Male

Locations

Sdr. Boulevard 29, Odense C, 5000, Denmark

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
Enrollment Status: Terminated
Publish Date: October 01, 2024
Intervention Type: Drug
Study Drug: Obeticholic Acid
Study Phase: Phase 3
A Phase 4, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Effect of Obeticholic Acid on Clinical Outcomes in Patients With Primary Biliary Cholangitis
A Phase 4, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Effect of Obeticholic Acid on Clinical Outcomes in Patients With Primary Biliary Cholangitis
Enrollment Status: Terminated
Publish Date: March 09, 2023
Intervention Type: Drug
Study Drug: Obeticholic Acid 
Study Phase: Phase 4
View 1 Less Clinical Trial

298 Total Publications

Clinical trial design, biomarkers and end points in metabolic and alcohol-related liver disease.
Clinical trial design, biomarkers and end points in metabolic and alcohol-related liver disease.
Journal: Nature reviews. Gastroenterology & hepatology
Published: August 28, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Krag's expertise for a condition
ConditionClose
View All 14 Advanced Conditions
View All 8 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile